Delivery Order SPE2DB20D2104-SPE2DB24FU89R
Award Date
6/26/24
Potential Completion Date
6/27/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,856.40 contract is a Firm Fixed Price Delivery Order for Lantus 100 Unit/ML Vial 10ML, a specialty medication used for treating diabetes. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,109.16 Firm Fixed Price Delivery Order contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription medication used to treat diabetes. The contract has an ultimate completion date of January 17, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,236.06 delivery order contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription medication used for the treatment of diabetes. The contract has a firm fixed price pricing type and does not have any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,155.77 delivery order contract is for the supply of Lantus 100 unit/ml vial (10 ml), a specialty medication used for the treatment of diabetes. The contract has an ultimate completion date of May 31, 2023 and is a firm fixed-price agreement. This award is part of a larger Indefinite Delivery Contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,278.10, is a delivery order for the supply of Lantus 100 unit/mL vial 10mL, a diabetes medication. The contract has an ultimate completion date of April 21, 2025 and is a firm fixed-price contract. This award is not associated with a set-aside program and is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $2,159.44, is for the delivery of Lantus 100 unit/mL vials. This is a firm fixed-price delivery order contract with an ultimate completion date of August 24, 2021. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,187.40 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of LANTUS 100 UNIT/ML VIAL 10ML, a prescription insulin medication. The contract has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,695.70, is for the delivery of Lantus 100 unit/ml vial 10ml, a specialty medication used for diabetes management. This is a firm fixed-price delivery order contract with a completion date of September 20, 2023. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $15,584.70 delivery order is for LANTUS 100 UNIT/ML VIAL 10ML and has a completion date of July 18, 2023. The contract is a firm fixed-price, with no set-aside designation indicated. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide LANTUS 100 UNIT/ML VIAL 10ML worth $2,374.80. The contract is a delivery order with a firm fixed price that runs through April 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a wide range of pharmaceutical products and...